Dr. Lenze is the Wallace and Lucille Renard professor of psychiatry and a director of the Healthy Mind Lab and the Mobile Health Research Core in the Institute of Clinical and Traditional Science.
His work has earned the Healthy Mind Lab funding from multiple philanthropic foundations, as well as $60 million in funding from the National Institutes of Health, and he recently received international distinction for his work proving that the psychiatric drug fluvoxamine was an effective treatment for COVID-19.
Dr. Lenze received his undergraduate and medical degrees from Washington University in St. Louis and joined the university’s faculty in 2007, where he has been recognized multiple times with teaching awards.
At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.
